Systems and methods for quantification and presentation of medical risk arising from unknown factors

作者: Jessica Oesterheld , Howard C. Coleman , Robert D. Patterson , Rajeev V. Pany , Kristine Ashcraft

DOI:

关键词:

摘要: Example methods of quantifying known and unknown risks an adverse drug event in individual based on various factors are disclosed. In some embodiments, include drug-drug interactions phenotypes cytochromes. Quantification may be severity the event/and or probability occurrence embodiments. displaying quantified risk also one embodiment, individuals is aggregated to display a population.

参考文章(71)
Robert A Branch, Marjorie Romkes, Methods of assessment of drug metabolizing enzymes ,(2004)
Julius Schopka, Ivar Helgason, Halldor Skulason, Hjortur Sturluson, Drug advice expert ,(2002)
Julia Kirchheiner, Ingolf Meineke, Gunnar Muller, Ivar Roots, Jurgen Brockmoller, Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers. Pharmacogenetics. ,vol. 12, pp. 571- 580 ,(2002) , 10.1097/00008571-200210000-00010
Sam M. Schulte, Michael A. Homewood, Robert V. Montz, Daniel A. Cooper, Kristen L. Hostetter, William A. Bruns, System, method, and computer program product for analyzing drug interactions ,(2009)
Michael D Kane, Nicholas V Iannotti, Jon E Sprague, John A Springer, Method for patient genotyping ,(2009)
Guenther Heinrich, Ivar Roots, System and method for optimizing drug therapy ,(2004)